☆ 4.6 Article

Rapid efficacy of anifrolumab across multiple subtypes of recalcitrant cutaneous lupus erythematosus parallels changes in discrete subsets of blood transcriptomic and cellular biomarkers

BRITISH JOURNAL OF DERMATOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Rheumatology

Gene Expression and Autoantibody Analysis Revealing Distinct Ancestry-Specific Profiles Associated With Response to Rituximab in Refractory Systemic Lupus Erythematosus

Lucy M. Carter et al.

Summary: Gene expression profiles in systemic lupus erythematosus (SLE) patients are associated with clinical features and treatment response. The study suggests that ancestry plays a central role in the immunologic and clinical heterogeneity of SLE, and that ancestry, disease activity, and transcriptional signatures could be helpful in predicting the effectiveness of B cell depletion therapies.

ARTHRITIS & RHEUMATOLOGY (2023)

Add to Collection

Article Rheumatology

Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials

Eric F. Morand et al.

Summary: This post-hoc analysis aimed to evaluate the efficacy of anifrolumab on organ domain-specific SLE disease activity. The results demonstrated that anifrolumab treatment improved multiple organ systems in SLE patients, particularly the musculoskeletal system, mucocutaneous system, and immunological system.

LANCET RHEUMATOLOGY (2022)

Add to Collection

Article Cell Biology

Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation

Allison C. Billi et al.

Summary: This study analyzed the skin and circulating immune cells of lupus patients using integrated single-cell RNA sequencing and spatial RNA sequencing. The findings reveal that the normal-appearing skin of patients with lupus is characterized by an interferon-rich environment and that CD16+ dendritic cells undergo interferon education in the skin, leading to proinflammatory phenotypes. These results provide important insights into the pathogenesis of cutaneous lupus erythematosus.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Acute skin exposure to ultraviolet light triggers neutrophil-mediated kidney inflammation

Sladjana Skopelja-Gardner et al.

Summary: Exposure to UV light triggers a neutrophil-dependent injury response in the kidney, leading to subclinical renal inflammation and injury. Neutrophils not only migrate to the skin but also to the kidney post UV light exposure, contributing to the renal induction of inflammation and injury genes. Patients with lupus have blood neutrophils similar to those observed in mice post-UV exposure, suggesting a potential role of these cells in mediating inflammation and injury.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Add to Collection

Article Immunology

B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity

Lisa Abernathy-Close et al.

Summary: Cutaneous lupus erythematosus (CLE) is a chronic inflammatory skin disease that commonly occurs in patients with systemic lupus erythematosus (SLE) and can also develop in the absence of systemic disease. Research has shown that skin-associated B cell responses distinguish CLE subtypes, with B cell function possibly being an important link between cutaneous lupus and systemic disease activity.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Dermatology

Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. Secukinumab

Heena Mehta et al.

Summary: This study identified the major IL-23+ mononuclear phagocyte and IL-17+T-cell subsets in psoriatic skin lesions, as well as revealed the changes in cellular composition before and during treatment with guselkumab or secukinumab.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Trial of Anifrolumab in Active Systemic Lupus Erythematosus

Eric F. Morand et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Rheumatology

B Cell Tetherin: A Flow Cytometric Cell-Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus

Yasser M. El-Sherbiny et al.

ARTHRITIS & RHEUMATOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity

Antonios Psarras et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Review Rheumatology

Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies

Joerg Wenzel

NATURE REVIEWS RHEUMATOLOGY (2019)

Add to Collection

Article Economics

Valuing health-related quality of life: An EQ-5D-5L value set for England

Nancy J. Devlin et al.

HEALTH ECONOMICS (2018)

Add to Collection

Article Rheumatology

Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa

Mrinal K. Sarkar et al.

ANNALS OF THE RHEUMATIC DISEASES (2018)

Add to Collection

Article Multidisciplinary Sciences

Non-classical monocytes are biased progenitors of wound healing macrophages during soft tissue injury

Claire E. Olingy et al.

SCIENTIFIC REPORTS (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients

Romain Banchereau et al.

CELL (2016)

Add to Collection

Article Rheumatology

Responses to Rituximab Suggest B Cell-Independent Inflammation in Cutaneous Systemic Lupus Erythematosus

Edward M. Vital et al.

ARTHRITIS & RHEUMATOLOGY (2015)

Add to Collection

Article Rheumatology

Modular Transcriptional Repertoire Analyses of Adults With Systemic Lupus Erythematosus Reveal Distinct Type I and Type II Interferon Signatures

Laurent Chiche et al.

ARTHRITIS & RHEUMATOLOGY (2014)

Add to Collection

Article Rheumatology

Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials

Susan Manzi et al.

ANNALS OF THE RHEUMATIC DISEASES (2012)

Add to Collection

Article Hematology

Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets

Kok Loon Wong et al.

BLOOD (2011)

Add to Collection

Article Rheumatology

Development and validation of a disease-specific health-related quality of life measure, the LupusQoL, for adults with systemic lupus erythematosus

Kathleen McElhone et al.

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)

Add to Collection

Article Dermatology

The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An outcome instrument for cutaneous lupus erythematosus

J Albrecht et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.